[Form 4] Healthcare Realty Trust Incorporated Insider Trading Activity

Rhea-AI Filing Summary

Julie F. Wilson, EVP and Chief Administrative Officer and a director of Healthcare Realty Trust Inc. (HR), reported a sale of 15,000 shares of HR common stock on 09/05/2025 at a reported price of $18 per share. After the transaction she beneficially owned 113,419 shares. The Form 4 was submitted under power of attorney by Andrew E. Loope.

Positive

• Timely disclosure of the insider sale via Form 4, including transaction date, price, and post-transaction holdings
• Clear reporting of the reporting person’s roles (EVP, Chief Administrative Officer and director) and use of power of attorney for filing

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Officer/director sale disclosed, reducing insider holdings but record appears routine and properly filed.

The filing shows an insider sale by a senior officer who also serves as a director. The transaction was reported on Form 4 and executed via power of attorney, indicating procedural compliance with Section 16 reporting requirements. The size of the sale relative to the remaining holding is visible but the filing contains no explanation for the sale, and no derivative or plan-based transactions are disclosed.

Securities Analyst

TL;DR: Insider disposed of 15,000 shares; filing provides clear post-sale ownership and price but no further context.

The Form 4 documents a straightforward non-derivative sale of common stock at $18 per share with post-transaction beneficial ownership of 113,419 shares. There are no related derivative transactions or option exercises reported. The disclosure is concise and meets standard reporting norms but offers no information on intent or broader pattern of trades.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilson Julie F.

(Last) (First) (Middle)

3310 WEST END AVENUE, SUITE 700

SUITE 700, ATTENTION: ANDREW LOOPE

(Street)

NASHVILLE TN 37203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Healthcare Realty Trust Inc [ HR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Admin. Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2025		S		15,000	D	$18	113,419	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Andrew E. Loope as power of attorney	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Healthcare Realty Trust (HR) report on 09/05/2025?

Julie F. Wilson reported a sale of 15,000 shares of HR common stock on 09/05/2025 at a price of $18 per share.

How many HR shares does Julie F. Wilson own after the reported sale?

The Form 4 reports that Julie F. Wilson beneficially owned 113,419 shares following the transaction.

What is Julie F. Wilson’s role at Healthcare Realty Trust (HR)?

The filing lists Julie F. Wilson as an EVP, Chief Administrative Officer and a director of the company.

Who signed the Form 4 for Julie F. Wilson?

The Form 4 was signed under power of attorney by Andrew E. Loope on 09/05/2025.

Were any derivative securities or option transactions disclosed in this Form 4?

No. The filing shows only a non-derivative sale of common stock and contains no reported derivative transactions.